Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04743908 · ClinicalTrials.gov registry record · NA
Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 1,328
- Enrollment target
NCT04743908: Completed NA study, sponsored by University of Chicago.
NCT04743908 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 1,328 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04743908, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,328 participants
- Enrollment target
Study Summary
This C3 project, Community network-driven COVID-19 testing of vulnerable populations in the Central US, will implement and evaluate a COVID-19 testing and vaccination approach that combines an evidence-based Social Network Testing Strategy (SNS) with community developed COVID-19 public health messages (SNS+). C3 will engage two disenfranchised populations across rural and urban sites in states across the Central US (Texas (TX), Louisiana (LA), Arkansas (AR), Indiana (IN), Illinois (IL)). C3 leverages NIDA's Justice Community Opioid Innovation Network (JCOIN), the PIs' extensive community located COVID-19 testing programs, and a network of established community partnerships. The collaborative community-academic partnerships, research and engagement infrastructure, and team's leadership across JCOIN will ensure that C3 can rapidly recruit, enroll and test most disenfranchised community members, (n=2400) and through this process, accelerate any forthcoming COVID-19 public health prevention interventions. C3 focuses on two communities most impacted by COVID-19: 1) Criminal justice involved (CJI) - non-incarcerated people with previous history of arrest/jail/prison, probation/parole, drug-court attendance, witnessed or experienced a negative interaction with police or law enforcement; and 2) Low-income Latinx - community members at 250% or below Federal Poverty Level. Both of these diverse populations, and the overlap between them, have some of the highest rates of COVID-19 infection and death in the United States. Messaging that affirms individual agency and corrects misinformation, combined with accessible and acceptable testing, is required to accelerate COVID-19 prevention for these populations.Using a two-arm randomized controlled trial design, participants will be enrolled into the Social Network testing Strategy (SNS) arm (involves social networking referrals only) or the Social Network testing Strategy with COVID-19 prevention messages (SNS+) messaging arm. The l
Primary Outcome
Network tested is measured at the participant level by the number of network members that are tested through the SNS.
Interventions
- OTHER Social Network Strategy + COVID-19 messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,328 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04743908 record still lists
NCT04743908 is an interventional study that assigns participants to a tested intervention. Its 1,328 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Social Network Strategy + COVID-19 messaging is the first listed.
NCT04743908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04743908 about?
NCT04743908 is a clinical study titled "Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US". This C3 project, Community network-driven COVID-19 testing of vulnerable populations in the Central US, will implement and evaluate a COVID-19 testing and vaccination approach that combines an evidence-based Social Network Testing Strategy (SNS) with community developed COVID-19 public health messag...
What is the current status of trial NCT04743908?
This trial is currently completed. It is a NA study. The enrollment target is 1,328 participants. The study started on 2021-04-29. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04743908?
The interventions under investigation include: Social Network Strategy + COVID-19 messaging (OTHER).
Who is sponsoring clinical trial NCT04743908?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04743908's enrollment target sits among peer trials
1,328 75th of 2000 higher than 1,926 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05889182 · 1,328 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI